MedTrace Logo

Steady State Serum and Epithelial Lining Fluid (ELF) Antibiotics Concentrations Under Continous Infusion

NCT00435305 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2008-06-09

No results posted yet for this study

Summary

The purpose of our study is to determine the penetration of continuously infused antibiotics at steady state, mainly Meropenem, Vancomycin, Linezolid, Piperacillin/tazobactam and additionally cefepim and ceftazidim, into epithelial lining fluid.

Conditions

Interventions

DRUG

Meropenem

DRUG

Vancomycin

DRUG

Linezolid

DRUG

Piperacillin/Tazobactam

DRUG

Cefepim

DRUG

Ceftazidim

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Wolfgang Krueger, PHD · Universitätsklinikum Tübingen, Klinik für Anästhesiologie und Intensivmedizin

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Completion
2007-11-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00435305 on ClinicalTrials.gov